Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Vivaldi Biosciences Logo
Vivaldi Biosciences Growth Score
10
CB Rank
393594
Heat Score
19
Vivaldi Biosciences develops influenza vaccines and therapeutics for seasonal and pandemic influenza.
Founded
obfuscation
PrivateVenture - Series Unknown New York, New York, United States11-50 www.vivaldibiosciences.com
Biotechnology
Life Science
Medical Device
Overview

Vivaldi Biosciences
Total Funding
obfuscation
Growth Score
10
Heat Score
19

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score10
-19 pts
in past quarter
Heat Score 19
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Vivaldi Biosciences

CB Rank
393594
Vivaldi Biosciences develops influenza vaccines and therapeutics for seasonal and pandemic influenza.
Founded
obfuscation
PrivateVenture - Series Unknown New York, New York, United States11-50 www.vivaldibiosciences.com
Biotechnology
Life Science
Medical Device

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Vivaldi Biosciences Inc.
Operating Status Active
Company Type For Profit
Founders  Adolfo García-Sastre, Elliott Kieff, Peter Palese
About the Company
Vivaldi Biosciences Inc. develops influenza vaccines and therapeutics for seasonal and pandemic influenza through a small molecule program targeting the NS1 protein of influenza. The company was founded in 2006 and is based in San Francisco, California.
Phone Number 6464720130
Contact Email info@vivaldibiosciences.com
Predictions & Insights

Growth Insight

See this Growth Insight
Vivaldi Biosciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

DeltaFLU
A nasal spray universal influenza vaccine designed to protect against all influenza strains, both seasonal and pandemic, for all age groups.
Delta-19
A nasal spray combination vaccine for Covid-19 and universal influenza, aimed at providing protection against both diseases simultaneously.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Vivaldi Biosciences Logo
Venture Round - Vivaldi Biosciences
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Board Members and Advisors 2 Contacts 6

Employee Profiles

Board Members and Advisors

News

News and Press

News•Nov 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 8, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 10, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

496
350.91%
 in past month

IT Spend

$90.7KThis year, Vivaldi Biosciences is projected to spend $90.7K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Processing Equipment Logo
Processing Equipment
84
Online Sales Logo
Online Sales
84
Cultivate Logo
Cultivate
84

Actively Used Products

11Vivaldi Biosciences uses 11 technology products and services including HTML5, GoDaddy Premium DNS, and  Adobe Fonts, according to G2 Stack.

Active Website Tech Count

2Vivaldi Biosciences is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Vivaldi Biosciences's headquarters? Vivaldi Biosciences is located in New York, New York, United States.Who invested in Vivaldi Biosciences? Vivaldi Biosciences has 3 investors including Bay City Capital and  NGN Capital.When was the last funding round for Vivaldi Biosciences? Vivaldi Biosciences closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Vivaldi Biosciences's competitors? Alternatives and possible competitors to Vivaldi Biosciences may include Sanofi, AstraZeneca, and  Altimmune.How much funding has Vivaldi Biosciences raised to date? Vivaldi Biosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3120884 1)
|